Autoantibodies (AA) are a serological hallmark of most autoimmune diseases. In contrast to
genetic markers that show a predisposition for disease development, certain AA serve as …

Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which
occurs in both genders, and across racial/ethnic and age groups; however, higher rates are …

Objective To understand the epidemiology, current treatment, and disease burden of
systemic lupus erythematosus (SLE) in the Asia Pacific (APAC) region. Methods A targeted …

Autoimmune diseases have a complex etiology and despite great progress having been
made in our comprehension of these disorders, there has been limited success in the …

Objectives To estimate the incidence and prevalence of systemic lupus erythematosus (SLE)
in the UK over the period 1999–2012. Methods A retrospective cohort study using the …

Systemic lupus erythematosus (SLE) may be more prevalent among most ethnic groups in
the low-and-middle income countries (LMICs), still these countries are under-represented in …

Objectives: To investigate mortality, cause of death, and risk factors related to mortality in
Japanese patients with rheumatoid arthritis (RA). Methods: The IORRA cohort is a large …

Objective To compare mortality rates, underlying causes of death, excess mortality, and
years of potential life lost (YPLL) among patients with rheumatoid arthritis (RA) relative to the …

Abstract Background & Aims There are few population‐based studies of the incidence and
mortality of autoimmune hepatitis. The burden of the disease and how it has changed over …

Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease with a
significant disease burden across the world among different ethnic, racial, and age groups …